entertainment -WSS

entertainment

author：hotspot 2025-09-09 05:35:25 - browse：2

FDA stop sign — Sarah Silbiger/Getty Images

The Food and Drug Administration is cracking down on websites that claim to sell the underlying chemicals of popular diabetes and obesity drugs like Ozempic, Wegovy, and Zepbound, saying that the websites are selling unapproved and misbranded drug products.

The regulator this week posted warning letters that it sent to two websites, Synthetix Inc. DBA Helix Chemical Supply and US Chem Labs. Though those websites say their chemicals are “for research use” and “not for human consumption,” the FDA said it found evidence on their pages showing that their products are indeed intended for human use, such as information about dosing and claims about the clinical benefits of the products.

The two websites did not immediately respond to requests for comment. The FDA said they have 15 working days to respond and detail the steps they’ve taken to address any violations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

hotspot

WSS

Flagship Pioneering startup Sonata Therapeutics lays off 21

Biden administration opens offers in Medicare drug price negotiations

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

What we need to know about Arena Bioworks

What we need to know about Arena Bioworks

Researchers tackle phage therapy hurdles for wider adoption

focus

entertainment

focus

How one medical school became remarkably diverse

Surprise medical billing ban raises prices elsewhere

After affirmative action ruling, medical educators look to 'holistic review'

Flagship Pioneering startup Sonata Therapeutics lays off 21

BioMarin wins approval for gene therapy to treat hemophilia A

Researchers tackle phage therapy hurdles for wider adoption

Anesthesiologist group: stop taking Ozempic before surgery

Researchers tackle phage therapy hurdles for wider adoption

Affirmative action in medical school literally saved lives

ARCH Venture Partners is raising $3 billion for a life sciences fund

hotspot

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Cognito secures funding to test medical device for Alzheimer's

Measles policy set amid Florida outbreak alarms vaccine proponents

Juul spent big to court Black leaders to promote its e

What we need to know about Arena Bioworks

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

hotspot

leisure time

hotspot

explore